Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Day

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2017
CCD Camera Detection of HIV InfectionJohn R Day
Methods in Molecular Biology (Clifton, N.J.)|January 20, 2009
CCD camera detection of HIV infectionJohn R Day
Journal of Virology|January 15, 2004
The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivityJohn R Day, Carsten Münk, John C Guatelli
Virology|August 15, 2006
The effect of the membrane-proximal tyrosine-based sorting signal of HIV-1 gp41 on viral infectivity depends on sequences within gp120John R Day, Nanette Van Damme, John C Guatelli
Cancer Letters|November 25, 2010
PCA3: from basic molecular science to the clinical labJohn R Day, Matthias Jost, Mark A Reynolds, et al.
Journal of Virological Methods|August 1, 2006
A computer-based, image-analysis method to quantify HIV-1 infection in a single-cycle infectious center assayJohn R Day, Laura E Martínez, Roman Sásik, et al.
Journal of Virology|February 1, 2005
Leucine-specific, functional interactions between human immunodeficiency virus type 1 Nef and adaptor protein complexesScott H Coleman, Nanette Van Damme, John R Day, et al.
The Journal of Urology|August 19, 2008
Predicting prostate cancer risk through incorporation of prostate cancer gene 3Donna Pauler Ankerst, Jack Groskopf, John R Day, et al.
Molecular Cancer|July 6, 2010
Molecular assays for the detection of prostate tumor derived nucleic acids in peripheral bloodMatthias Jost, John R Day, Ryan Slaughter, et al.
BJU International|February 9, 2012
Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkersNeesha C Dhani, Urban Emmenegger, Laurie Adams, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2017
CCD Camera Detection of HIV InfectionJohn R Day
Methods in Molecular Biology (Clifton, N.J.)|January 20, 2009
CCD camera detection of HIV infectionJohn R Day
Journal of Virology|January 15, 2004
The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivityJohn R Day, Carsten Münk, John C Guatelli
Virology|August 15, 2006
The effect of the membrane-proximal tyrosine-based sorting signal of HIV-1 gp41 on viral infectivity depends on sequences within gp120John R Day, Nanette Van Damme, John C Guatelli
Cancer Letters|November 25, 2010
PCA3: from basic molecular science to the clinical labJohn R Day, Matthias Jost, Mark A Reynolds, et al.
Journal of Virological Methods|August 1, 2006
A computer-based, image-analysis method to quantify HIV-1 infection in a single-cycle infectious center assayJohn R Day, Laura E Martínez, Roman Sásik, et al.
Journal of Virology|February 1, 2005
Leucine-specific, functional interactions between human immunodeficiency virus type 1 Nef and adaptor protein complexesScott H Coleman, Nanette Van Damme, John R Day, et al.
The Journal of Urology|August 19, 2008
Predicting prostate cancer risk through incorporation of prostate cancer gene 3Donna Pauler Ankerst, Jack Groskopf, John R Day, et al.
Molecular Cancer|July 6, 2010
Molecular assays for the detection of prostate tumor derived nucleic acids in peripheral bloodMatthias Jost, John R Day, Ryan Slaughter, et al.
BJU International|February 9, 2012
Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkersNeesha C Dhani, Urban Emmenegger, Laurie Adams, et al.
Pageof 2